The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Zoledronic acid 4 mg/5 ml concentrate for solution for infusion

4/5 milligram(s)/millilitre Concentrate for solution for infusion

Fresenius Kabi Deutschland GmbHPA2059/019/001

Main Information

Trade NameZoledronic acid 4 mg/5 ml concentrate for solution for infusion
Active SubstancesZoledronic acid
Strength4/5 milligram(s)/millilitre
Dosage FormConcentrate for solution for infusion
Licence HolderFresenius Kabi Deutschland GmbH
Licence NumberPA2059/019/001

Group Information

ATC CodeM05BA Bisphosphonates
M05BA08 zoledronic acid

Status

Authorised/WithdrawnAuthorised
Licence Issued12/10/2012
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (See:Summary of Product Characteristics, section 4.2).
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back